Philip Cowen

• Vulnerability to depression is associated with a failure to acquire implicit social appraisals.

  Bayliss AP. et al, (2017), Cogn Emot, 31, 825 - 833

• Brain glutamate in anorexia nervosa: a magnetic resonance spectroscopy case control study at 7 Tesla.

  Godlewska BR. et al, (2017), Psychopharmacology (Berl), 234, 421 - 426

• Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies.

  Petersen I. et al, (2017), Clin Epidemiol, 9, 95 - 103

• Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration.

  Vai B. et al, (2016), Eur Neuropsychopharmacol, 26, 2000 - 2010

• Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records.

  Petersen I. et al, (2016), Schizophr Res, 176, 349 - 356

• Effects of typhoid vaccine on inflammation and sleep in healthy participants: a double-blind, placebo-controlled, crossover study.

  Sharpley AL. et al, (2016), Psychopharmacology (Berl), 233, 3429 - 3435

• Can saliva testing replace blood measurements for health monitoring? Insights from a correlation study of salivary and whole blood glutathione in humans.

  Ngamchuea K. et al, (2016), Analyst, 141, 4707 - 4712

• Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing.

  Masaki C. et al, (2016), Psychopharmacology (Berl), 233, 2655 - 2661

• Altered states: psilocybin for treatment-resistant depression.

  Cowen P., (2016), Lancet Psychiatry, 3, 592 - 593

• Cognitive mechanisms of diazepam administration: a healthy volunteer model of emotional processing.

  Pringle A. et al, (2016), Psychopharmacology (Berl), 233, 2221 - 2228

• Frontal Cortex Stimulation Reduces Vigilance to Threat: Implications for the Treatment of Depression and Anxiety.

  Ironside M. et al, (2016), Biol Psychiatry, 79, 823 - 830

• Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records.

  Petersen I. et al, (2016), Health Technol Assess, 20, 1 - 176

• Presynaptic Serotoninergic Regulation of Emotional Processing: A Multimodal Brain Imaging Study.

  Selvaraj S. et al, (2015), Biol Psychiatry, 78, 563 - 571

• β-Adrenoceptor blockade modulates fusiform gyrus activity to black versus white faces.

  Terbeck S. et al, (2015), Psychopharmacology (Berl), 232, 2951 - 2958

• Acute fluoxetine modulates emotional processing in young adult volunteers.

  Capitão LP. et al, (2015), Psychol Med, 45, 2295 - 2308

• What has serotonin to do with depression?

  Cowen PJ. and Browning M., (2015), World Psychiatry, 14, 158 - 160

• Effects of seven-day diazepam administration on resting-state functional connectivity in healthy volunteers: A randomized, double-blind study

  Pflanz CP. et al, (2015), Psychopharmacology, 232, 2139 - 2147

• Tianeptine in an experimental medicine model of antidepressant action.

  Cooper CM. et al, (2015), J Psychopharmacol, 29, 582 - 590

• Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers

  Schmidt K. et al, (2015), Psychopharmacology, 232, 1793 - 1801

• Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.

  Cleare A. et al, (2015), J Psychopharmacol, 29, 459 - 525

• Lithium prescribing during pregnancy: A UK primary care database study

  McCrea RL. et al, (2015), PLoS ONE, 10

• How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia.

  Freeman D. et al, (2015), Schizophr Bull, 41, 391 - 399

• Early effects of tianeptine on emotional processing in healthy volunteers

  Cooper CM. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S68 - S69

• Anomalous emotional processing in depression, and its significance for treatment

  Harmer C. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S57 - S58

• Neurochemistry of major depression: a study using magnetic resonance spectroscopy.

  Godlewska BR. et al, (2015), Psychopharmacology (Berl), 232, 501 - 507

• Decision making in young people at familial risk of depression.

  Mannie ZN. et al, (2015), Psychol Med, 45, 375 - 380

• Short-term escitalopram treatment and hippocampal volume.

  Godlewska BR. et al, (2014), Psychopharmacology (Berl), 231, 4579 - 4581

• Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity.

  Murray E. et al, (2014), Psychopharmacology (Berl), 231, 4323 - 4335

• Short-term escitalopram treatment and hippocampal volume

  Godlewska BR. et al, (2014), Psychopharmacology, 231, 4579 - 4581

• Structural and functional imaging of the hippocampus in young people at familial risk of depression.

  Mannie ZN. et al, (2014), Psychol Med, 44, 2939 - 2948

• Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers

  Schmidt K. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S191 - S191

• Genome-wide association study of antidepressant-induced sexual dysfunction in depressed males

  Crawford A. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S373 - S374

• Effects of short-term diazepam administration on resting-state functional connectivity in healthy adults

  Pflanz CP. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S311 - S311

• Discontinuation of antipsychotic medication in pregnancy: a cohort study.

  Petersen I. et al, (2014), Schizophr Res, 159, 218 - 225

• Discontinuation of antipsychotic medication in pregnancy: A cohort study

  Petersen I. et al, (2014), SCHIZOPHRENIA RESEARCH, 159, 218 - 225

• Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.

  Wiles NJ. et al, (2014), Psychol Med, 44, 2855 - 2866

• Preliminary evidence that sub-chronic citalopram triggers the re-evaluation of value in intimate partnerships.

  Bilderbeck AC. et al, (2014), Soc Cogn Affect Neurosci, 9, 1419 - 1425

• Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.

  Crawford AA. et al, (2014), Psychopharmacology (Berl), 231, 2921 - 2931

• Serotonin and social norms: tryptophan depletion impairs social comparison and leads to resource depletion in a multiplayer harvesting game.

  Bilderbeck AC. et al, (2014), Psychol Sci, 25, 1303 - 1313

• Using neuroimaging to identify neural markers of familial vulnerability to depression

  Cowen P., (2014), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 17, 10 - 10

• Tyrosine-free amino acid mixtures reduce physiologically-evoked release of dopamine in a selective and activity-dependent manner.

  Le Masurier M. et al, (2014), J Psychopharmacol, 28, 561 - 569

• Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic.

  Diamond PR. et al, (2014), J Psychopharmacol, 28, 536 - 544

• Ebselen as a novel IMPase inhibitor as a lithium mimetic

  Churchill G. et al, (2014), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 17, 5 - 6

• Early changes in neural responses to emotional information predict clinical response to antidepressant treatment in depression

  Godlewska B. et al, (2014), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 17, 82 - 82

• Behavioural characterisation of ebselen; a potential lithium-mimetic

  Singh N. et al, (2014), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 17, 132 - 133

• When less is more: a functional magnetic resonance imaging study of verbal working memory in remitted depressed patients.

  Norbury R. et al, (2014), Psychol Med, 44, 1197 - 1203

• I want to help you, but I am not sure why: gaze-cuing induces altruistic giving.

  Rogers RD. et al, (2014), J Exp Psychol Gen, 143, 763 - 777

• Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers

  Schmidt K. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S74 - S74

• Effect of interferon-α on cortical glutamate in patients with hepatitis C: a proton magnetic resonance spectroscopy study.

  Taylor MJ. et al, (2014), Psychol Med, 44, 789 - 795

• Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trial.

  Sharpley AL. et al, (2014), J Affect Disord, 167, 306 - 311

• Effects of short-term varenicline administration on cortisol in healthy, non-smoking adults: a randomized, double-blind, study.

  Mocking RJ. et al, (2014), Psychopharmacology (Berl), 231, 143 - 148

• Cortical glutathione levels in young people with bipolar disorder: A pilot study using magnetic resonance spectroscopy

  Godlewska BR. et al, (2014), Psychopharmacology, 231, 327 - 332

• Cortical glutathione levels in young people with bipolar disorder: a pilot study using magnetic resonance spectroscopy.

  Godlewska BR. et al, (2014), Psychopharmacology (Berl), 231, 327 - 332

• Corrigendum to Beta adrenergic blockade reduces utilitarian judgment [Biol. Psychol. 92 (2) (2013) 323-328]

  Sylvia T. et al, (2014), Biological Psychology, 97

• Corrigendum to 'Beta adrenergic blockade reduces utilitarian judgement' [Biol. Psychol., 92, (2013), 323-328] doi:10.1016/j.biopsycho.2012.09.005

  Terbeck S. et al, (2014), Biological Psychology, 103

• Corrigendum to "Beta adrenergic blockade reduces utilitarian judgment" [Biol. Psychol. 92 (2) (2013) 323-328] (DOI:10.1016/j.biopsycho.2012.09.005)

  Sylvia T. et al, (2014), Biological Psychology

• Adverse effects from antidepressant treatment: Randomised controlled trial of 601 depressed individuals

  Crawford AA. et al, (2014), Psychopharmacology, 231, 2921 - 2931

• Early markers of cognitive enhancement: developing an implicit measure of cognitive performance.

  Pringle A. et al, (2013), Psychopharmacology (Berl), 230, 631 - 638

• Early Changes in Neural Responses to Emotional Information Predict Clinical Response to SSRI Treatment in Depression

  Godlewska B. et al, (2013), NEUROPSYCHOPHARMACOLOGY, 38, S446 - S446

• Psychobiotics highlight the pathways to happiness.

  Burnet PW. and Cowen PJ., (2013), Biol Psychiatry, 74, 708 - 709

• Unedited in vivo detection and quantification of γ-aminobutyric acid in the occipital cortex using short-TE MRS at 3T

  Near J. et al, (2013), NMR in Biomedicine, 26, 1353 - 1362

• Unedited in vivo detection and quantification of γ-aminobutyric acid in the occipital cortex using short-TE MRS at 3 T.

  Near J. et al, (2013), NMR Biomed, 26, 1353 - 1362

• 'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.

  Harmer CJ. and Cowen PJ., (2013), Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 368

• Serotonin, depression and antidepressant action

  Cowen P., (2013), SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 19, 94 - 94

• Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline?

  Pringle A. et al, (2013), J Psychopharmacol, 27, 719 - 731

• Behavioral Neurobiology of Depression and Its Treatment

  Cowen PJ. et al, (2013), Current Topics in Behavioral Neurosciences, 14

• The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression.

  Cowen P. and Sherwood AC., (2013), J Psychopharmacol, 27, 575 - 583

• Effects of pramipexole on the processing of rewarding and aversive taste stimuli

  McCabe C. et al, (2013), Psychopharmacology, 228, 283 - 290

• Effects of pramipexole on the processing of rewarding and aversive taste stimuli.

  McCabe C. et al, (2013), Psychopharmacology (Berl), 228, 283 - 290

• Cardiovascular and metabolic risk profile in young people at familial risk of depression.

  Mannie ZN. et al, (2013), Br J Psychiatry, 203, 18 - 23

• The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: A meta-Analysis

  Murphy SE. et al, (2013), Molecular Psychiatry, 18, 512 - 520

• The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: A meta-Analysis

  Murphy SE. et al, (2013), Molecular Psychiatry, 18, 512 - 520

• The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: a meta-analysis.

  Murphy SE. et al, (2013), Mol Psychiatry, 18, 512 - 520

• Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study.

  Mocking RJ. et al, (2013), Neuropsychopharmacology, 38, 476 - 484

• Beta adrenergic blockade reduces utilitarian judgement.

  Terbeck S. et al, (2013), Biol Psychol, 92, 323 - 328

• Classification of depressive disorders.

  Cowen PJ., (2013), Curr Top Behav Neurosci, 14, 3 - 13

• 'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.

  Harmer CJ. and Cowen PJ., (2013), Philos Trans R Soc Lond B Biol Sci, 368

• Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.

  Godlewska BR. et al, (2012), Psychol Med, 42, 2609 - 2617

• Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study.

  Selvaraj S. et al, (2012), Mol Psychiatry, 17, 1254 - 1260

• Measuring endogenous changes in serotonergic neurotransmission in humans: A [¹¹C] CUMI-101 PET challenge study

  Selvaraj S. et al, (2012), Molecular Psychiatry, 17, 1254 - 1260

• Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine.

  Pringle A. et al, (2012), J Psychopharmacol, 26, 1417 - 1423

• Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartate.

  Taylor MJ. et al, (2012), Int J Neuropsychopharmacol, 15, 1541 - 1546

• Current antidepressant treatments: what do we have and what do we need?

  Cowen PJ., (2012), INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 16, 10 - 11

• Using attentional bias modification as a cognitive vaccine against depression.

  Browning M. et al, (2012), Biol Psychiatry, 72, 572 - 579

• Neural processing of reward and punishment in young people at increased familial risk of depression.

  McCabe C. et al, (2012), Biol Psychiatry, 72, 588 - 594

• Neural processing of reward and punishment in young people at increased familial risk of depression

  McCabe C. et al, (2012), Biological Psychiatry, 72, 588 - 594

• Effect of interferon-alfa on cortical glutamate in patients with hepatitis C: a proton magnetic resonance spectroscopy study

  Godlewska BR. et al, (2012), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 22, S198 - S199

• Early increase in the neuronal marker N-acetyl-aspartate with antidepressant treatment of major depression

  Taylor MJ. et al, (2012), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 22, S265 - S265

• Brain serotonin neurotransmission and affect regulation in humans: a positron emission tomography study

  Selvaraj S. et al, (2012), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 22, S193 - S194

• Antidepressants and reward

  McCabe C. et al, (2012), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 22, S140 - S140

• Reply to Burchett, T.S. and Glenn, L.L. 'Measurement validity of tests for implicit negative bias'.

  Terbeck S. et al, (2012), Psychopharmacology (Berl), 222, 723 - 724

• Propranolol reduces implicit negative racial bias.

  Terbeck S. et al, (2012), Psychopharmacology (Berl), 222, 419 - 424

• Negative ion treatment increases positive emotional processing in seasonal affective disorder.

  Harmer CJ. et al, (2012), Psychol Med, 42, 1605 - 1612

• Experimental medicine model shows no depressogenic effects of varenicline

  Pringle A. et al, (2012), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 15, 153 - 153

• Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study.

  Taylor MJ. et al, (2012), J Psychopharmacol, 26, 733 - 737

• Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

  Taylor MJ. et al, (2012), JOURNAL OF PSYCHOPHARMACOLOGY, 26, 733 - 737

• In response to "The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?" by Trevor Norman.

  Sharpley AL. and Cowen PJ., (2012), Psychopharmacology (Berl), 221

• Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.

  Bould H. et al, (2012), J Psychopharmacol, 26, 663 - 669

• Detection of in vivo Brain Serotonin Release in Humans: A 11C-CUMI PET Study

  Selvaraj S. et al, (2012), BIOLOGICAL PSYCHIATRY, 71, 199S - 199S

• Severity of depression and response to antidepressants: GENPOD randomised controlled trial.

  Wiles NJ. et al, (2012), Br J Psychiatry, 200, 130 - 136

• Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine

  Pringle A. et al, (2012), JOURNAL OF PSYCHOPHARMACOLOGY, 26, 1417 - 1423

• Propranolol reduces implicit negative racial bias

  Terbeck S. et al, (2012), Psychopharmacology, 1 - 6

• Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

  Taylor MJ. et al, (2012), JOURNAL OF PSYCHOPHARMACOLOGY, 26, 733 - 737

• HOW DO ANTIDEPRESSANTS WORK? A POSITRON EMISSION TOMOGRAPHY (PET) STUDY OF BRAIN SEROTONIN LEVELS AND AFFECT REGULATION

  Selvaraj S. et al, (2012), EUROPEAN PSYCHIATRY, 27

• Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.

  Horder J. et al, (2012), J Psychopharmacol, 26, 125 - 132

• Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing

  Horder J. et al, (2012), JOURNAL OF PSYCHOPHARMACOLOGY, 26, 125 - 132

• Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial

  Bould H. et al, (2012), JOURNAL OF PSYCHOPHARMACOLOGY, 26, 663 - 669

• Efficient γ-aminobutyric acid editing at 3T without macromolecule contamination: MEGA-SPECIAL.

  Near J. et al, (2011), NMR Biomed, 24, 1277 - 1285

• Neural response to angry and disgusted facial expressions in bulimia nervosa.

  Ashworth F. et al, (2011), Psychol Med, 41, 2375 - 2384

• Imaging vulnerability for depression.

  Norbury R. et al, (2011), Mol Psychiatry, 16, 1067 - 1068

• The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers

  McCabe C. et al, (2011), Psychopharmacology, 217, 271 - 278

• The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers.

  McCabe C. et al, (2011), Psychopharmacology (Berl), 217, 271 - 278

• Efficacy markers in depression.

  Harmer CJ. et al, (2011), J Psychopharmacol, 25, 1148 - 1158

• Efficacy markers in depression

  Harmer CJ. et al, (2011), Journal of Psychopharmacology, 25, 1148 - 1158

• Agomelatine facilitates positive versus negative affective processing in healthy volunteer models.

  Harmer CJ. et al, (2011), J Psychopharmacol, 25, 1159 - 1167

• Agomelatine facilitates positive versus negative affective processing in healthy volunteer models

  Harmer CJ. et al, (2011), Journal of Psychopharmacology, 25, 1159 - 1167

• A cognitive neuropsychological model of antidepressant drug action.

  Pringle A. et al, (2011), Prog Neuropsychopharmacol Biol Psychiatry, 35, 1586 - 1592

• SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex

  McCabe C. et al, (2011), Molecular Psychiatry, 16, 592 - 594

• SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex.

  McCabe C. et al, (2011), Mol Psychiatry, 16, 592 - 594

• Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.

  Lewis G. et al, (2011), Br J Psychiatry, 198, 464 - 471

• Short-term NK1 receptor antagonism and emotional processing in healthy volunteers.

  Pringle A. et al, (2011), Psychopharmacology (Berl), 215, 239 - 246

• Has psychopharmacology got a future?

  Cowen PJ., (2011), Br J Psychiatry, 198, 333 - 335

• Decreased regional gray matter volume in S allele carriers of the 5-HTTLPR triallelic polymorphism

  Selvaraj S. et al, (2011), Molecular Psychiatry, 16, 472 - 473

• Serotonergic activity influences the cognitive appraisal of close intimate relationships in healthy adults.

  Bilderbeck AC. et al, (2011), Biol Psychiatry, 69, 720 - 725

• Frontolimbic responses to emotional faces in young people at familial risk of depression.

  Mannie ZN. et al, (2011), J Affect Disord, 130, 127 - 132

• Elevated cortical glutamate in young people at increased familial risk of depression.

  Taylor MJ. et al, (2011), Int J Neuropsychopharmacol, 14, 255 - 259

• Decreased neural response to fear after a short-term SSRI treatment: a 3T functional magnetic resonance imaging study

  Godlewska B. et al, (2011), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 21, S73 - S73

• Serotonin revisited.

  Cowen PJ. and Lucki I., (2011), Psychopharmacology (Berl), 213, 167 - 169

• Does agomelatine block 5-HT2C receptors in humans?

  Sharpley AL. et al, (2011), Psychopharmacology (Berl), 213, 653 - 655

• Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB.

  Selvaraj S. et al, (2011), Psychopharmacology (Berl), 213, 555 - 562

• 5-HT and depression: is the glass half-full?

  Sharp T. and Cowen PJ., (2011), Curr Opin Pharmacol, 11, 45 - 51

• Serotonin and dopamine play complementary roles in gambling to recover losses.

  Campbell-Meiklejohn D. et al, (2011), Neuropsychopharmacology, 36, 402 - 410

• A single dose of mirtazapine modulates neural responses to emotional faces in healthy people.

  Rawlings NB. et al, (2010), Psychopharmacology (Berl), 212, 625 - 634

• Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers.

  Horder J. et al, (2010), Int J Neuropsychopharmacol, 13, 1103 - 1113

• Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain.

  Murthy NV. et al, (2010), Neuroimage, 52, 50 - 54

• Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers.

  Taylor MJ. et al, (2010), J Psychopharmacol, 24, 1217 - 1221

• Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.

  Miskowiak KW. et al, (2010), Psychopharmacology (Berl), 210, 419 - 428

• 5-HT(1A) receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-(11)C]WAY-100635.

  Sargent PA. et al, (2010), J Affect Disord, 123, 77 - 80

• Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.

  Meyer PT. et al, (2010), Neuroimage, 50, 984 - 993

• Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review.

  Whale R. et al, (2010), J Psychopharmacol, 24, 513 - 520

• NK1 receptor antagonism and emotional processing in healthy volunteers.

  Chandra P. et al, (2010), J Psychopharmacol, 24, 481 - 487

• Increased neural response to fear in patients recovered from depression: a 3T functional magnetic resonance imaging study.

  Norbury R. et al, (2010), Psychol Med, 40, 425 - 432

• Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.

  McCabe C. et al, (2010), Biol Psychiatry, 67, 439 - 445

• A functional magnetic resonance imaging study of verbal working memory in young people at increased familial risk of depression.

  Mannie ZN. et al, (2010), Biol Psychiatry, 67, 471 - 477

• Short-term NK1 receptor antagonism and emotional processing in healthy volunteers

  Pringle A. et al, (2010), Psychopharmacology, 1 - 8

• Not fade away: the HPA axis and depression.

  Cowen PJ., (2010), Psychol Med, 40, 1 - 4

• Normal glutamate but elevated myo-inositol in anterior cingulate cortex in recovered depressed patients.

  Taylor MJ. et al, (2009), J Affect Disord, 119, 186 - 189

• High-density negative ion treatment increases positive affective memory.

  Malcolm CP. et al, (2009), Psychol Med, 39, 1930 - 1932

• Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.

  Miskowiak KW. et al, (2009), Psychopharmacology (Berl), 207, 133 - 142

• Short-term antidepressant treatment modulates amygdala response to happy faces.

  Norbury R. et al, (2009), Psychopharmacology (Berl), 206, 197 - 204

• NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers.

  McCabe C. et al, (2009), Int J Neuropsychopharmacol, 12, 1261 - 1274

• Effect of acute antidepressant administration on negative affective bias in depressed patients.

  Harmer CJ. et al, (2009), Am J Psychiatry, 166, 1178 - 1184

• A big tent?

  Cowen PJ., (2009), Psychiatric Bulletin, 33

• The role of serotonin in nonnormative risky choice: the effects of tryptophan supplements on the "reflection effect" in healthy adult volunteers.

  Murphy SE. et al, (2009), J Cogn Neurosci, 21, 1709 - 1719

• Neural representation of reward in recovered depressed patients.

  McCabe C. et al, (2009), Psychopharmacology (Berl), 205, 667 - 677

• Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action.

  Harmer CJ. et al, (2009), Br J Psychiatry, 195, 102 - 108

• Commentary on STAR*D: a summary and UK perspective.

  Cowen PJ., (2009), J Psychopharmacol, 23, 618 - 619

• Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers.

  Horder J. et al, (2009), Psychopharmacology (Berl), 205, 85 - 91

• Negative self-beliefs in relation to eating disorder and depressive symptoms: Different themes are characteristic of the two sets of symptoms in those with eating disorders and/or depression

  Cooper MJ. and Cowen P., (2009), Journal of Cognitive Psychotherapy, 23, 147 - 159

• Effect of a single dose of citalopram on amygdala response to emotional faces.

  Murphy SE. et al, (2009), Br J Psychiatry, 194, 535 - 540

• Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers.

  Di Simplicio M. et al, (2009), J Psychopharmacol, 23, 241 - 248

• Memory impairment in young women at increased risk of depression: influence of cortisol and 5-HTT genotype.

  Mannie ZN. et al, (2009), Psychol Med, 39, 757 - 762

• Early effects of mirtazapine on emotional processing.

  Arnone D. et al, (2009), Psychopharmacology (Berl), 203, 685 - 691

• Brain serotonin transporter binding in former users of MDMA ('ecstasy').

  Selvaraj S. et al, (2009), Br J Psychiatry, 194, 355 - 359

• Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.

  Murphy SE. et al, (2009), Int J Neuropsychopharmacol, 12, 169 - 179

• NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers

  McCabe C. et al, (2009), International Journal of Neuropsychopharmacology, 1 - 14

• Wake-up call for British psychiatry Reply

  Craddock N. et al, (2008), BRITISH JOURNAL OF PSYCHIATRY, 193, 517 - 517

• Emotional face processing in women with high and low levels of eating disorder related symptoms.

  Jones L. et al, (2008), Eat Behav, 9, 389 - 397

• Authors' reply

  Craddock N. et al, (2008), British Journal of Psychiatry, 193

• The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study.

  Norbury R. et al, (2008), Mol Psychiatry, 13, 1011 - 1020

• Serotonin and depression: pathophysiological mechanism or marketing myth?

  Cowen PJ., (2008), Trends Pharmacol Sci, 29, 433 - 436

• Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers.

  Harmer CJ. et al, (2008), Psychopharmacology (Berl), 199, 495 - 502

• Direct effects of diazepam on emotional processing in healthy volunteers.

  Murphy SE. et al, (2008), Psychopharmacology (Berl), 199, 503 - 513

• Effects of citalopram on cortical glutamate and glutamine in healthy volunteers are localised: a proton magnetic resonance spectroscopic study

  Taylor M. et al, (2008), FUNDAMENTAL & CLINICAL PHARMACOLOGY, 22, 109 - 109

• Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls.

  Hinz R. et al, (2008), J Cereb Blood Flow Metab, 28, 1478 - 1490

• Augmentation of SSRI treatment

  Cowen P., (2008), FUNDAMENTAL & CLINICAL PHARMACOLOGY, 22, 116 - 116

• Wake-up call for British psychiatry.

  Craddock N. et al, (2008), Br J Psychiatry, 193, 6 - 9

• Frontal glutamate and glutamine normalized after recovery front major depressive disorder: A proton magnetic resonance spectroscopy study

  Taylor M. et al, (2008), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 11, 102 - 103

• Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy

  Taylor M. et al, (2008), JOURNAL OF PSYCHOPHARMACOLOGY, 22, 473 - 476

• Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy.

  Taylor M. et al, (2008), J Psychopharmacol, 22, 473 - 476

• Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.

  Anderson IM. et al, (2008), J Psychopharmacol, 22, 343 - 396

• GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.

  Thomas L. et al, (2008), Trials, 9

• Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression.

  Mannie ZN. et al, (2008), Br J Psychiatry, 192, 356 - 361

• Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients.

  Bhagwagar Z. et al, (2008), Int J Neuropsychopharmacol, 11, 255 - 260

• 'It's not over when it's over': persistent neurobiological abnormalities in recovered depressed patients.

  Bhagwagar Z. and Cowen PJ., (2008), Psychol Med, 38, 307 - 313

• 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.

  Bhagwagar Z. et al, (2007), Am J Psychiatry, 164, 1858 - 1865

• Effects of acute tyrosine depletion on subjective craving and selective processing of smoking-related cues in abstinent cigarette smokers.

  Munafò MR. et al, (2007), J Psychopharmacol, 21, 805 - 814

• Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations.

  Hafizi S. et al, (2007), Br J Psychiatry, 191, 282 - 284

• Impaired emotional categorisation in young people at increased familial risk of depression.

  Mannie ZN. et al, (2007), Neuropsychologia, 45, 2975 - 2980

• Single dose antidepressant administration modulates the neural processing of self-referent personality trait words.

  Miskowiak K. et al, (2007), Neuroimage, 37, 904 - 911

• Reply to Low-Dose Tryptophan Depletion

  Cowen PJ. et al, (2007), Biological Psychiatry, 62, 543 - 544

• A single dose of citalopram increases fear recognition in healthy subjects.

  Browning M. et al, (2007), J Psychopharmacol, 21, 684 - 690

• Human 5-HT transporter availability predicts amygdala reactivity in vivo.

  Rhodes RA. et al, (2007), J Neurosci, 27, 9233 - 9237

• Effects of alpha-lactalbumin on emotional processing in healthy women.

  Scrutton H. et al, (2007), J Psychopharmacol, 21, 519 - 524

• Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study.

  Norbury R. et al, (2007), Br J Psychiatry, 190, 531 - 532

• Increased waking salivary cortisol levels in young people at familial risk of depression.

  Mannie ZN. et al, (2007), Am J Psychiatry, 164, 617 - 621

• Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects.

  Bhagwagar Z. et al, (2007), Biol Psychiatry, 61, 806 - 812

• Emotional bias and waking salivary cortisol in relatives of patients with major depression.

  Le Masurier M. et al, (2007), Psychol Med, 37, 403 - 410

• Emotional bias and waking salivary cortisol in relatives of patients with major depression

  Masurier ML. et al, (2007), Psychological Medicine, 37, 403 - 410

• Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.

  Hinz R. et al, (2007), J Cereb Blood Flow Metab, 27, 161 - 172

• Lack of effect of chromium supplementation on mental state and body weight in people with schizophrenia.

  Hockney RA. et al, (2006), J Clin Psychopharmacol, 26, 544 - 545

• Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.

  Bhagwagar Z. et al, (2006), Am J Psychiatry, 163, 1580 - 1587

• Dopaminergic agents

  Cowen P., (2006), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 16, S172 - S172

• Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers.

  Murphy SE. et al, (2006), Psychopharmacology (Berl), 187, 121 - 130

• Tryptophan depletion does not lower brain GABA levels in healthy volunteers.

  Selvaraj S. et al, (2006), Psychopharmacology (Berl), 187, 131 - 132

• Increased cortisol levels in young people at high risk of depression

  Mannie Z. et al, (2006), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 9, S173 - S173

• Emotional processing and attention in young people at high risk of depression

  Mannie Z. et al, (2006), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 9, S102 - S103

• Pharmacology of drugs used in the treatment of mood disorders

  Gartside S. and Cowen P., (2006), Psychiatry, 5, 162 - 166

• Antidepressant drug treatment modifies the neural processing of nonconscious threat cues.

  Harmer CJ. et al, (2006), Biol Psychiatry, 59, 816 - 820

• 5HT(3) antagonism abolishes the emotion potentiated startle effect in humans.

  Harmer CJ. et al, (2006), Psychopharmacology (Berl), 186, 18 - 24

• Effect of acute tyrosine depletion in using a branched chain amino-acid mixture on dopamine neurotransmission in the rat brain.

  Le Masurier M. et al, (2006), Neuropsychopharmacology, 31, 310 - 317

• Increased salivary cortisol after waking in depression.

  Bhagwagar Z. et al, (2005), Psychopharmacology (Berl), 182, 54 - 57

• The effects of a branched chain amino acid mixture supplemented with tryptophan on biochemical indices of neurotransmitter function and decision-making.

  Scarnà A. et al, (2005), Psychopharmacology (Berl), 179, 761 - 768

• Fluoxetine improves minor depressive disorders.

  Cowen PJ., (2005), Evid Based Ment Health, 8

• Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.

  Sharpley AL. et al, (2005), J Clin Psychiatry, 66, 450 - 454

• Lack of effect of tyrosine depletion on mood in recovered depressed women.

  McTavish SF. et al, (2005), Neuropsychopharmacology, 30, 786 - 791

• Enhanced early morning salivary cortisol in neuroticism.

  Portella MJ. et al, (2005), Am J Psychiatry, 162, 807 - 809

• Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms.

  Hayward G. et al, (2005), Biol Psychiatry, 57, 517 - 524

• Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.

  Cowen PJ. et al, (2005), Curr Med Res Opin, 21, 345 - 356

• Tyrosine depletion in recovered depressed women

  Mannie Z. et al, (2004), JOURNAL OF PSYCHOPHARMACOLOGY, 18, A16 - A16

• Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?

  Rabiner EA. et al, (2004), Neuropsychopharmacology, 29, 1688 - 1698

• Neuroticism as a psychological vulnerability factor for mood disorders

  Portella MJ. et al, (2004), JOURNAL OF PSYCHOPHARMACOLOGY, 18, A12 - A12

• Methamphetamine activates reward circuitry in drug naïve human subjects.

  Völlm BA. et al, (2004), Neuropsychopharmacology, 29, 1715 - 1722

• Elevated waking cortisol levels in neuroticism: A biological vulnerability factor for depressive disorders?

  Portella MJ. et al, (2004), JOURNAL OF PSYCHOPHARMACOLOGY, 18, A11 - A11

• Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.

  Nadeem HS. et al, (2004), Neuropsychopharmacology, 29, 1699 - 1703

• Antidepressant drug treatment modifies subliminal emotional processing in the amygdala

  Harmer CJ. et al, (2004), JOURNAL OF PSYCHOPHARMACOLOGY, 18, A12 - A12

• Tyrosine depletion does not cause depressive relapse in antidepressant-treated patients.

  McTavish SF. et al, (2004), Psychopharmacology (Berl), 175, 124 - 126

• Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.

  Harmer CJ. et al, (2004), Am J Psychiatry, 161, 1256 - 1263

• Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.

  Bhagwagar Z. et al, (2004), Mol Psychiatry, 9, 386 - 392

• A 5-HT2C receptor promoter polymorphism (HTR2C - 759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes.

  Pooley EC. et al, (2004), Am J Med Genet B Neuropsychiatr Genet, 126B, 124 - 127

• Tyrosine-free amino acid mixture attenuates amphetamine-induced displacement of [11C]raclopride in striatum in vivo: a rat PET study.

  Le Masurier M. et al, (2004), Synapse, 51, 151 - 157

• Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor.

  Bhagwagar Z. et al, (2004), Am J Psychiatry, 161, 368 - 370

• Fos immunocytochemical studies on the neuroanatomical sites of action of acute tyrosine depletion in the rat brain.

  Le Masurier M. et al, (2004), Psychopharmacology (Berl), 171, 435 - 440

• Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression.

  Bhagwagar Z. et al, (2004), Am J Psychiatry, 161, 166 - 168

• The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5-HT function.

  Attenburrow MJ. et al, (2003), Psychol Med, 33, 1381 - 1386

• Lack of effect of a single dose of hydrocortisone on serotonin(1A) receptors in recovered depressed patients measured by positron emission tomography with [11C]WAY-100635.

  Bhagwagar Z. et al, (2003), Biol Psychiatry, 54, 890 - 895

• Reduction of brain dopamine concentration with dietary tyrosine plus phenylalanine depletion: an [11C]raclopride PET study.

  Montgomery AJ. et al, (2003), Am J Psychiatry, 160, 1887 - 1889

• Increase in concentration of waking salivary cortisol in recovered patients with depression.

  Bhagwagar Z. et al, (2003), Am J Psychiatry, 160, 1890 - 1891

• Neural correlates of the subjective effects of i.v. amphetamine: an fMRI study in healthy volunteers

  Vollm BA. et al, (2003), JOURNAL OF PSYCHOPHARMACOLOGY, 17, A73 - A73

• Can we measure 5-HT release with PET?

  Grasby PM. et al, (2003), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 13, S110 - S110

• Acute reboxetine administration increases plasma and salivary cortisol.

  Hill SA. et al, (2003), J Psychopharmacol, 17, 273 - 275

• Acute administration of nutritionally sourced tryptophan increases fear recognition.

  Attenburrow MJ. et al, (2003), Psychopharmacology (Berl), 169, 104 - 107

• Tryptophan depletion decreases the recognition of fear in female volunteers.

  Harmer CJ. et al, (2003), Psychopharmacology (Berl), 167, 411 - 417

• Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity.

  Harmer CJ. et al, (2003), Am J Psychiatry, 160, 990 - 992

• Impairments in working memory associated with naturalistic dieting in women: no relationship between task performance and urinary 5-HIAA levels.

  Green MW. et al, (2003), Appetite, 40, 145 - 153

• GABA and mood disorders.

  Taylor M. et al, (2003), Psychol Med, 33, 387 - 393

• Contrasting effects of citalopram and reboxetine on waking salivary cortisol.

  Harmer CJ. et al, (2003), Psychopharmacology (Berl), 167, 112 - 114

• Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis.

  UK ECT Review Group None., (2003), Lancet, 361, 799 - 808

• Effects of a branched-chain amino acid drink in mania.

  Scarna A. et al, (2003), Br J Psychiatry, 182, 210 - 213

• Dietary supplementation with vitamins, minerals, and fatty acids reduced antisocial behaviour in young adult prisoners: Commentary

  Gesch CB. et al, (2003), Evidence-Based Medicine, 8

• Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients.

  Sharpley AL. et al, (2003), J Clin Psychiatry, 64, 192 - 196

• Antidepressants and emotional processing

  Harmer CJ. et al, (2003), Neuropsychopharmacology, 28, 1384 - 1385

• Acute SSRI administration affects the processing of social cues in healthy volunteers.

  Harmer CJ. et al, (2003), Neuropsychopharmacology, 28, 148 - 152

• Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressed patients.

  Bhagwagar Z. et al, (2002), J Affect Disord, 72, 249 - 255

• Predictors of mood response to acute tryptophan depletion. A reanalysis.

  Booij L. et al, (2002), Neuropsychopharmacology, 27, 852 - 861

• Cerebellar responses during anticipation of noxious stimuli in subjects recovered from depression. Functional magnetic resonance imaging study.

  Smith KA. et al, (2002), Br J Psychiatry, 181, 411 - 415

• Augmentation strategies: 5-HT and beyond

  Cowen P., (2002), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 12, S139 - S139

• The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers.

  Murphy FC. et al, (2002), Psychopharmacology (Berl), 163, 42 - 53

• Acute citalopram administration produces correlated increases in plasma and salivary cortisol.

  Bhagwagar Z. et al, (2002), Psychopharmacology (Berl), 163, 118 - 120

• Acute administration of citalopram facilitates memory consolidation in healthy volunteers.

  Harmer CJ. et al, (2002), Psychopharmacology (Berl), 163, 106 - 110

• Attenuation of preferential occupancy of 5-HT1A autoreceptors by pindolol in depressed patients: effect of SSRIs or an endophenotype of the depressed state?

  Rabiner E. et al, (2002), NEUROIMAGE, 16, S67 - S67

• Mood, eating behaviour and attention.

  Williams JM. et al, (2002), Psychol Med, 32, 469 - 481

• A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function.

  Gijsman HJ. et al, (2002), Psychopharmacology (Berl), 160, 192 - 197

• A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables.

  Rabiner EA. et al, (2002), Neuroimage, 15, 620 - 632

• Predictors of mood response to acute tryptophan depletion: A reanalysis

  Booij L. et al, (2002), JOURNAL OF AFFECTIVE DISORDERS, 68, 103 - 103

• Chromium treatment decreases the sensitivity of 5-HT2A receptors.

  Attenburrow MJ. et al, (2002), Psychopharmacology (Berl), 159, 432 - 436

• State and trait abnormalities in serotonin function in major depression.

  Bhagwagar Z. et al, (2002), Br J Psychiatry, 180, 24 - 28

• Effect of branch chain amino acids supplemented with tryptophan on tyrosine availability and plasma prolactin.

  Scarnà A. et al, (2002), Psychopharmacology (Berl), 159, 222 - 223

• Biochemical stress of caring

  Davis JMD. and Cowen PJ., (2001), PSYCHOLOGICAL MEDICINE, 31, 1475 - 1478

• Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness.

  McTavish SF. et al, (2001), Br J Psychiatry, 179, 356 - 360

• Tyrosine depletion attenuates the behavioural stimulant effects of amphetamine and cocaine in rats.

  McTavish SF. et al, (2001), Eur J Pharmacol, 424, 115 - 119

• The effect of Li 1370, extract of Ginkgo biloba, on REM sleep in humans.

  Murray BJ. et al, (2001), Pharmacopsychiatry, 34, 155 - 157

• Researching the antidepressant actions of Hypericum perforatum (St. John's wort) in animals and man.

  Franklin M. and Cowen PJ., (2001), Pharmacopsychiatry, 34 Suppl 1, S29 - S37

• Effect of a low tryptophan diet on the prolactin responses to the 5-HT2A agonist DOI in the rat.

  Franklin M. and Cowen PJ., (2001), Pharmacopsychiatry, 34, 147 - 149

• A database of [11C]WAY-100635 binding ins healthy volunteers: relationship to demographic, physiological and personality variables

  Rabiner E. et al, (2001), NEUROIMAGE, 13, S1090 - S1090

• Low-dose citalopram as a 5-HT neuroendocrine probe.

  Attenburrow MJ. et al, (2001), Psychopharmacology (Berl), 155, 323 - 326

• Decreased tryptophan availability but normal post-synaptic 5-HT2c receptor sensitivity in chronic fatigue syndrome.

  Vassallo CM. et al, (2001), Psychol Med, 31, 585 - 591

• Decreased sensitivity of 5-HT(1D) receptors in melancholic depression.

  Whale R. et al, (2001), Br J Psychiatry, 178, 454 - 457

• Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressives

  Bhagwagar Z. and Cowen PJ., (2001), BIOLOGICAL PSYCHIATRY, 49, 51S - 52S

• Administration of the beta-adrenoceptor blocker propranolol impairs the processing of facial expressions of sadness.

  Harmer CJ. et al, (2001), Psychopharmacology (Berl), 154, 383 - 389

• Tyrosine depletion attenuates dopamine function in healthy volunteers.

  Harmer CJ. et al, (2001), Psychopharmacology (Berl), 154, 105 - 111

• Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine.

  Sharpley AL. et al, (2001), Psychopharmacology (Berl), 153, 271 - 272

• Repetitive transcranial magnetic stimulation to right prefrontal cortex does not modulate the psychostimulant effects of amphetamine.

  Clark L. et al, (2000), Int J Neuropsychopharmacol, 3, 297 - 302

• 5-HT1A receptor binding in panic disorder; comparison with depressive disorder and healthy volunteers using PET and [11C]WAY-100635

  Sargent P. et al, (2000), NeuroImage, 11

• beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy.

  Rabiner EA. et al, (2000), Neuropsychopharmacology, 23, 285 - 293

• Psychopharmacology of 5-HT(1A) receptors.

  Cowen PJ., (2000), Nucl Med Biol, 27, 437 - 439

• Drug action at the 5-HT(1A) receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-(11)C]WAY-100635.

  Rabiner EA. et al, (2000), Nucl Med Biol, 27, 509 - 513

• Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.

  Whale R. et al, (2000), Psychopharmacology (Berl), 150, 120 - 122

• Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.

  Sharpley AL. et al, (2000), Biol Psychiatry, 47, 468 - 470

• Does mirtazapine enhance serotonergic neurotransmission in depressed patients?

  Whale R. et al, (2000), Psychopharmacology (Berl), 148, 325 - 326

• Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment.

  Sargent PA. et al, (2000), Arch Gen Psychiatry, 57, 174 - 180

• Modelling a loss event: effect of imagined bereavement on the hypothalamic-pituitary-adrenal axis.

  McCleery JM. et al, (2000), Psychol Med, 30, 219 - 223

• Impaired regulation of brain serotonin function during dieting in women recovered from depression.

  Smith KA. et al, (2000), Br J Psychiatry, 176, 72 - 75

• Acute effects of LI 160 (extract of Hypericum perforatum, St John's wort) and two of its constituents on neuroendocrine responses in the rat.

  Franklin M. et al, (2000), J Psychopharmacol, 14, 360 - 363

• Twin studies and the etiology of eating disorders.

  Fairburn CG. et al, (1999), Int J Eat Disord, 26, 349 - 358

• Comparison of the effects of alpha-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo.

  McTavish SF. et al, (1999), J Psychopharmacol, 13, 379 - 384

• Slow, repetitive transcranial magnetic stimulation was effective for major depression

  Klein E. and Cowen PJ., (1999), Evidence-Based Medicine, 4

• Slow, repetitive transcranial magnetic stimulation was effective for major depression: Commentary

  Cowen PJ., (1999), Evidence-Based Mental Health, 2

• Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers.

  Franklin M. et al, (1999), Biol Psychiatry, 46, 581 - 584

• The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers.

  Young AH. et al, (1999), Psychopharmacology (Berl), 145, 260 - 266

• Covariation of activity in habenula and dorsal raphé nuclei following tryptophan depletion.

  Morris JS. et al, (1999), Neuroimage, 10, 163 - 172

• Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors?

  Whale R. et al, (1999), Psychopharmacology (Berl), 145, 223 - 226

• Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion.

  Smith KA. et al, (1999), Br J Psychiatry, 174, 525 - 529

• Allelic variation of the 5-HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorder.

  Burnet PW. et al, (1999), Psychiatr Genet, 9, 101 - 104

• Allelic variation in the 5-HT2C receptor (HTR2C) and functional responses to the 5-HT2C receptor agonist, m-chlorophenylpiperazine.

  Quested DJ. et al, (1999), Psychopharmacology (Berl), 144, 306 - 307

• Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.

  Gartside SE. et al, (1999), Br J Pharmacol, 127, 145 - 152

• Symptomatic relapse in bulimia nervosa following acute tryptophan depletion.

  Smith KA. et al, (1999), Arch Gen Psychiatry, 56, 171 - 176

• Serotonin, dieting, and bulimia nervosa.

  Cowen PJ. and Smith KA., (1999), Adv Exp Med Biol, 467, 101 - 104

• Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release.

  McTavish SF. et al, (1999), Psychopharmacology (Berl), 141, 182 - 188

• Effect of a long-term low tryptophan diet on the prolactin responses to the 5-HT1A and 5-HT2C agonists, 8-OH-DPAT and mCPP in the male rat.

  Franklin M. et al, (1999), J Psychopharmacol, 13, 58 - 63

• Attenuation of some subjective effects of amphetamine following tyrosine depletion.

  McTavish SF. et al, (1999), J Psychopharmacol, 13, 144 - 147

• Probing the function of 5-HT<inf>1B/1D</inf> receptors in psychiatric patients

  Whale R. and Cowen PJ., (1998), CNS Spectrums, 3, 40 - 45

• Clomipramine enhances the cortisol response to 5-HTP: implications for the therapeutic role of 5-HT2 receptors.

  Sargent PA. et al, (1998), Psychopharmacology (Berl), 140, 120 - 122

• Antidepressant-like effect of Hypericum perforatum (St John's wort) on the sleep polysomnogram.

  Sharpley AL. et al, (1998), Psychopharmacology (Berl), 139, 286 - 287

• Sumatriptan lowers plasma prolactin in healthy female volunteers.

  Whale R. and Cowen PJ., (1998), Psychopharmacology (Berl), 137, 203 - 204

• Sertraline treatment does not increase plasma prolactin levels in healthy subjects.

  Gordon C. et al, (1998), Psychopharmacology (Berl), 137, 201 - 202

• Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo.

  Clifford EM. et al, (1998), Br J Pharmacol, 124, 206 - 212

• Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment.

  Williams JH. et al, (1998), Br J Psychiatry, 172, 243 - 249

• Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.

  Young AH. et al, (1998), Psychopharmacology (Berl), 136, 198 - 200

• Back to the future: the neurobiology of major depression.

  Cowen PJ., (1998), Psychol Med, 28, 253 - 255

• Increased prolactin responses to d-fenfluramine in obsessive-compulsive disorder - Author's reply

  Cowen PJ., (1998), BRITISH JOURNAL OF PSYCHIATRY, 172, 187 - 187

• Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).

  Young AH. et al, (1998), Biol Psychiatry, 43, 236 - 237

• Effect of venlafaxine on pineal melatonin and noradrenaline in the male rat.

  Franklin M. et al, (1998), J Psychopharmacol, 12, 371 - 374

• Brain 5-HT neurotransmission during paroxetine treatment.

  Sargent PA. et al, (1998), Br J Psychiatry, 172, 49 - 52

• SSRI treatment decreases prolactin and hyperthermic responses to mCPP.

  Quested DJ. et al, (1997), Psychopharmacology (Berl), 133, 305 - 308

• Haloperidol enhances latent inhibition in visual tasks in healthy people.

  Williams JH. et al, (1997), Psychopharmacology (Berl), 133, 262 - 268

• 5-HT2C receptor activation decreases appetite and body weight in obese subjects.

  Sargent PA. et al, (1997), Psychopharmacology (Berl), 133, 309 - 312

• Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine.

  Fineberg NA. et al, (1997), Br J Psychiatry, 171, 280 - 282

• Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity.

  Sargent P. et al, (1997), Psychopharmacology (Berl), 132, 296 - 302

• Increased brain serotonin function in men with chronic fatigue syndrome.

  Sharpe M. et al, (1997), BMJ, 315, 164 - 165

• Tryptophan and depression - Reply

  Smith KA. et al, (1997), LANCET, 349, 1553 - 1554

• Relapse of depression after rapid depletion of tryptophan.

  Smith KA. et al, (1997), Lancet, 349, 915 - 919

• Sumatriptan decreases food intake and increases plasma growth hormone in healthy women.

  Boeles S. et al, (1997), Psychopharmacology (Berl), 129, 179 - 182

• Intravenous administration of haloperidol to healthy volunteers: lack of subjective effects but clear objective effects.

  Williams JH. et al, (1997), J Psychopharmacol, 11, 247 - 252

• Effect of tryptophan depletion on mood in male and female volunteers: A pilot study

  Smith KA. et al, (1997), HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 12, 111 - 117

• Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission.

  Cowen PJ. and Sargent PA., (1997), J Psychopharmacol, 11, 345 - 348

• Assessment and treatment of insomnia (including a case control study of patients with Primary Insomnia).

  Sharpley AL. et al, (1997), Int J Psychiatry Clin Pract, 1, 107 - 117

• Antipsychotic drug effects in a model of schizophrenic attentional disorder: a randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people.

  Williams JH. et al, (1996), Biol Psychiatry, 40, 1135 - 1143

• Do authors know who refereed their paper? A questionnaire survey.

  Wessely S. et al, (1996), BMJ, 313

• Increased prolactin response to buspirone in chronic fatigue syndrome.

  Sharpe M. et al, (1996), J Affect Disord, 41, 71 - 76

• Schizotypy and height: Reduced height in high-schizotypal healthy men

  Wellman NA. et al, (1996), Personality and Individual Differences, 21, 823 - 825

• Moderate dieting causes 5-HT2C receptor supersensitivity.

  Cowen PJ. et al, (1996), Psychol Med, 26, 1155 - 1159

• 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.

  Park SB. et al, (1996), Psychol Med, 26, 1191 - 1196

• The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.

  Sharpley AL. et al, (1996), Psychopharmacology (Berl), 126, 50 - 54

• Low dose melatonin improves sleep in healthy middle-aged subjects.

  Attenburrow ME. et al, (1996), Psychopharmacology (Berl), 126, 179 - 181

• Advances in psychopharmacology: mood disorders and dementia.

  Cowen PJ., (1996), Br Med Bull, 52, 539 - 555

• Effect of nefazodone and lithium on sleep architecture in healthy men

  Sharpley AL. et al, (1996), Journal of Psychopharmacology, 10, 26 - 29

• Case-control study of evening melatonin concentration in primary insomnia.

  Attenburrow ME. et al, (1996), BMJ, 312, 1263 - 1264

• Effects of GR 68755 on d-amphetamine-induced changes in mood, cognitive performance, appetite, food preference, and caloric and macronutrient intake in humans.

  Johnson BA. et al, (1996), Behav Pharmacol, 7, 216 - 227

• Paroxetine treatment and the prolactin response to sumatriptan.

  Wing YK. et al, (1996), Psychopharmacology (Berl), 124, 377 - 379

• Schizophrenics show reduced stroop interference if long-latency responses are excluded

  Williams JH. et al, (1996), SCHIZOPHRENIA RESEARCH, 18, XII20 - XII20

• Opposite treatment effects on negative priming in patients with affective psychoses or schizophrenia

  Williams JH. et al, (1996), SCHIZOPHRENIA RESEARCH, 18, XIII8 - XIII8

• Latent inhibition is not reduced in drug-free patients with schizophrenia

  Williams JH. et al, (1996), SCHIZOPHRENIA RESEARCH, 18, XIII2 - XIII2

• Haloperidol reduces stroop interference and increases negative priming in healthy people

  Williams JH. et al, (1996), SCHIZOPHRENIA RESEARCH, 18, XIII9 - XIII9

• Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugs.

  Delva NJ. et al, (1996), Biol Psychiatry, 39, 100 - 106

• Use of a dietary manipulation to deplete plasma tyrosine and phenylalanine in healthy subjects.

  Sheehan BD. et al, (1996), J Psychopharmacol, 10, 231 - 234

• Effect of valine on 5-HT neurotransmission and mood.

  Cowen PJ. et al, (1996), Adv Exp Med Biol, 398, 67 - 71

• Effect of castration and castration with hormone replacement on the plasma prolactin responses to neuroendocrine challenge with i.v. mCPP in the male rat following a low tryptophan diet.

  Franklin M. et al, (1996), J Psychopharmacol, 10, 250 - 253

• Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?

  Park SB. et al, (1995), Int Clin Psychopharmacol, 10, 215 - 220

• Melatonin phase advances circadian rhythm.

  Attenburrow ME. et al, (1995), Psychopharmacology (Berl), 121, 503 - 505

• IN-VIVO EVIDENCE THAT D-FENFLURAMINE RELEASES 5-HT FROM NERVE-TERMINALS OF BOTH THE DORSAL AND MEDIAN RAPHE NUCLEI

  MCQUADE R. et al, (1995), BRITISH JOURNAL OF PHARMACOLOGY, 116, P220 - P220

• Differential effects of clonidine, haloperidol, diazepam and tryptophan depletion on focused attention and attentional search.

  Coull JT. et al, (1995), Psychopharmacology (Berl), 121, 222 - 230

• Biochemical and behavioural effects of acute tryptophan depletion in abstinent bulimic subjects: a pilot study.

  Oldman A. et al, (1995), Psychol Med, 25, 995 - 1001

• Why is dieting so difficult.

  Cowen PJ. et al, (1995), Nature, 376

• Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.

  Williamson DJ. et al, (1995), Br J Psychiatry, 167, 238 - 242

• Ondansetron and opiate craving. A novel pharmacological approach to addiction.

  Sell LA. et al, (1995), Br J Psychiatry, 166, 511 - 514

• Effect of pindolol on the prolactin response to d-fenfluramine.

  Park SB. and Cowen PJ., (1995), Psychopharmacology (Berl), 118, 471 - 474

• Dieting decreases plasma tryptophan and increases the prolactin response to d-fenfluramine in women but not men.

  Walsh AE. et al, (1995), J Affect Disord, 33, 89 - 97

• Effect of pharmacologic treatments on the sleep of depressed patients.

  Sharpley AL. and Cowen PJ., (1995), Biol Psychiatry, 37, 85 - 98

• The effects of a low tryptophan diet on brain 5 -HT metabolism and 5-HT-mediated neuroendocrine responses in the male rat.

  Franklin M. et al, (1995), J Psychopharmacol, 9, 336 - 341

• Menstrual cycle effects on the action of buspirone on food intake in healthy female volunteers.

  Goodall EM. et al, (1995), J Psychopharmacol, 9, 307 - 312

• HYPOPHAGIC, ENDOCRINE AND SUBJECTIVE RESPONSES TO M-CHLOROPHENYLPIPERAZINE IN HEALTHY-MEN AND WOMEN

  COWEN P. et al, (1995), HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 10, 385 - 391

• p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.

  Series HG. et al, (1994), Psychopharmacology (Berl), 116, 508 - 514

• Selective serotonin reuptake inhibitors. Drugs related to tricyclic antidepressants are a mixed bag.

  Cowen P. and Thompson C., (1994), BMJ, 309

• Neuroendocrine responses to intravenous L-tryptophan in obsessive compulsive disorder.

  Fineberg NA. et al, (1994), J Affect Disord, 32, 97 - 104

• Effects of hydrocortisone on brain 5-HT function and sleep.

  Young AH. et al, (1994), J Affect Disord, 32, 139 - 146

• The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers.

  Silverstone PH. et al, (1994), Int Clin Psychopharmacol, 9, 173 - 178

• The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.

  Silverstone PH. and Cowen PJ., (1994), Biol Psychiatry, 36, 309 - 316

• m-Chlorophenylpiperazine decreases food intake in a test meal.

  Walsh AE. et al, (1994), Psychopharmacology (Berl), 116, 120 - 122

• Attenuation of the prolactin-stimulating and hyperthermic effects of nefazodone after subacute treatment.

  Walsh AE. and Cowen PJ., (1994), J Clin Psychopharmacol, 14, 268 - 273

• Tryptophan depletion in normal volunteers produces selective impairments in learning and memory.

  Park SB. et al, (1994), Neuropharmacology, 33, 575 - 588

• Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.

  Sharpley AL. et al, (1994), Neuropharmacology, 33, 467 - 471

• 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone.

  Cowen PJ. et al, (1994), Br J Psychiatry, 164, 372 - 379

• THE EFFECT OF TRYPTOPHAN ON BRAIN 5-HT FUNCTION - A REVIEW

  COWEN P., (1994), HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 9, 371 - 376

• Neuroendocrine effects of sumatriptan.

  Herdman JR. et al, (1994), Psychopharmacology (Berl), 113, 561 - 564

• HALOPERIDOL INCREASES LATENT INHIBITION IN HIGH SCHIZOTYPAL SUBJECTS

  WILLIAMS J. et al, (1994), SCHIZOPHRENIA RESEARCH, 11, 162 - 162

• Effect of acute tryptophan depletion on mood and appetite in healthy female volunteers.

  Oldman AD. et al, (1994), J Psychopharmacol, 8, 8 - 13

• Depression in the elderly.

  Cowen PJ., (1994), J Psychopharmacol, 8, 68 - 69

• 5-HT 2C receptor sensitivity during treatment with selective serotonin re-uptake inhibitors.

  Williams R. et al, (1994), J Psychopharmacol, 8, 168 - 170

• Buspirone-induced hypothermia in normal male volunteers.

  Young AH. et al, (1993), Biol Psychiatry, 34, 665 - 666

• ALCOHOL-INDUCED REINFORCEMENT - DOPAMINE AND 5-HT3 RECEPTOR INTERACTIONS IN ANIMALS AND HUMANS

  JOHNSON B. and COWEN P., (1993), DRUG DEVELOPMENT RESEARCH, 30, 153 - 169

• THE EFFECTS OF HYDROCORTISONE ON BUSPIRONE INDUCED NEUROENDOCRINE RESPONSES AND HYPOTHERMIA IN NORMAL VOLUNTEERS

  YOUNG A. et al, (1993), NEUROPSYCHOPHARMACOLOGY, 9, S59 - S60

• THE EFFECTS OF DIETING ON D-FENFLURAMINE INDUCED PROLACTIN RESPONSE

  WALSH A. et al, (1993), NEUROPSYCHOPHARMACOLOGY, 9, S68 - S68

• THE EFFECTS OF A LOW TRYPTOPHAN DIET ON PLASMA PROLACTIN FOLLOWING NEUROENDOCRINE CHALLENGES WITH MCPP AND D-FENFLURAMINE IN THE RAT

  FRANKLIN M. et al, (1993), NEUROPSYCHOPHARMACOLOGY, 9, S75 - S75

• MAKE-BELIEVE IN PSYCHIATRY OR THE PERILS OF PROGRESS - VANPRAAG,HM

  COWEN P., (1993), BRITISH JOURNAL OF PSYCHIATRY, 163, 420 - 421

• Effect of lofepramine on 5-HT function and sleep.

  Herdman JR. et al, (1993), J Affect Disord, 29, 63 - 72

• EFFECT OF ACUTE TRYPTOPHAN DEPLETION ON MOOD AND APPETITE IN HEALTHY FEMALE VOLUNTEERS

  OLDMAN D. et al, (1993), NEUROPSYCHOPHARMACOLOGY, 9, S91 - S91

• 5-HT RECEPTOR SENSITIVITY DURING ANTIDEPRESSANT DRUG-TREATMENT

  COWEN P., (1993), NEUROPSYCHOPHARMACOLOGY, 9, S23 - S24

• The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers.

  Grasby PM. et al, (1993), Psychol Med, 23, 605 - 612

• Low serum cholesterol and suicide.

  Hawthon K. et al, (1993), Br J Psychiatry, 162, 818 - 825

• Effect of lithium on the prolactin response to D-fenfluramine in healthy subjects.

  Power AC. et al, (1993), Biol Psychiatry, 33, 801 - 805

• Abnormalities of sleep in patients with the chronic fatigue syndrome.

  Morriss R. et al, (1993), BMJ, 306, 1161 - 1164

• Combination treatment of depression.

  Cowen PJ. and Power AC., (1993), Br J Psychiatry, 162, 266 - 267

• Neuroendocrine and temperature effects of nefazodone in healthy volunteers.

  Walsh AE. et al, (1993), Biol Psychiatry, 33, 115 - 119

• Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation.

  Cowen PJ., (1993), Clin Neuropharmacol, 16 Suppl 3, S6 - 18

• Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.

  Goodall EM. et al, (1993), Psychopharmacology (Berl), 112, 461 - 466

• Ondansetron and alcohol pharmacokinetics.

  Johnson BA. et al, (1993), Psychopharmacology (Berl), 112

• meta-Chlorophenylpiperazine decreases slow-wave sleep in humans.

  Katsuda Y. et al, (1993), Biol Psychiatry, 33, 49 - 51

• Attenuation of some alcohol-induced mood changes and the desire to drink by 5-HT3 receptor blockade: a preliminary study in healthy male volunteers.

  Johnson BA. et al, (1993), Psychopharmacology (Berl), 112, 142 - 144

• 5HT‐3 receptor blockade in nicotine withdrawal: Study with BRL 46470A

  Park SBG. et al, (1993), Human Psychopharmacology: Clinical and Experimental, 8, 345 - 349

• Fluoxetine and suicidal behaviour. Some clinical and theoretical aspects of a controversy.

  Power AC. and Cowen PJ., (1992), Br J Psychiatry, 161, 735 - 741

• EFFECT OF AMINO-ACID LOADS ON HIPPOCAMPAL 5-HT RELEASE INVITRO EVOKED BY ELECTRICAL-STIMULATION OF THE DORSAL RAPHE NUCLEUS AND D-FENFLURAMINE ADMINISTRATION

  GARTSIDE S. et al, (1992), BRITISH JOURNAL OF PHARMACOLOGY, 107, P448 - P448

• Fatal myocardial infarction and use of psychotropic drugs in young women.

  Thorogood M. et al, (1992), Lancet, 340, 1067 - 1068

• Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments.

  Gartside SE. et al, (1992), Eur J Pharmacol, 221, 27 - 33

• Single photon emission tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia.

  Geaney DP. et al, (1992), Biol Psychiatry, 32, 293 - 295

• Measuring the neuromodulatory effects of drugs in man with positron emission tomography.

  Friston KJ. et al, (1992), Neurosci Lett, 141, 106 - 110

• Nefazodone--a novel antidepressant--may increase REM sleep.

  Sharpley AL. et al, (1992), Biol Psychiatry, 31, 1070 - 1073

• Alpha-2-adrenoceptor control of cortisol and ACTH in normal volunteers: preliminary open trial of the effects of acute and chronic idazoxan.

  Glue P. et al, (1992), Psychoneuroendocrinology, 17, 261 - 266

• Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.

  da Roza Davis JM. et al, (1992), J Affect Disord, 24, 177 - 181

• Decreased 5-HT-mediated prolactin release in major depression.

  Anderson IM. et al, (1992), Br J Psychiatry, 160, 372 - 378

• The rewarding properties of alcohol are attenuated by 5-HT<inf>3</inf> receptor blockade

  Johnson BA. et al, (1992), European Neuropsychopharmacology, 2

• The effect of apomorphine and buspirone on regional cerebral blood flow during the performance of a cognitive task-measuring neuromodulatory effects of psychotropic drugs in man.

  Grasby PM. et al, (1992), Eur J Neurosci, 4, 1203 - 1212

• Slow wave sleep and 5-HT2 receptor sensitivity in generalised anxiety disorder: a pilot study with ritanserin.

  da Roza Davis JM. et al, (1992), Psychopharmacology (Berl), 108, 387 - 389

• Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine: a pilot study in healthy volunteers.

  Silverstone PH. et al, (1992), Int Clin Psychopharmacol, 7, 37 - 43

• ONDANSETRON ATTENUATES THE PSYCHOLOGICAL, BUT NOT THE PSYCHOMOTOR EFFECTS OF AMPHETAMINE

  SILVERSTONE P. and COWEN P., (1992), SCHIZOPHRENIA RESEARCH, 6, 119 - 120

• Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression.

  Power AC. and Cowen PJ., (1992), Mol Aspects Med, 13, 205 - 220

• Evidence that the large neutral amino acid L-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo.

  Gartside SE. et al, (1992), Psychopharmacology (Berl), 109, 251 - 253

• Effect of the 5-HT1A partial agonist buspirone on regional cerebral blood flow in man.

  Grasby PM. et al, (1992), Psychopharmacology (Berl), 108, 380 - 386

• Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers.

  Anderson IM. and Cowen PJ., (1992), Psychopharmacology (Berl), 106, 428 - 432

• Effect of oestradiol treatment on 5-HT and dopamine-mediated neuroendocrine responses.

  Best NR. et al, (1992), J Psychopharmacol, 6, 483 - 488

• Effect of estradiol implant on noradrenergic function and mood in menopausal subjects.

  Best NR. et al, (1992), Psychoneuroendocrinology, 17, 87 - 93

• Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis.

  Gartside SE. et al, (1992), Neuropharmacology, 31, 9 - 14

• Does ondansetron attenuate amphetamine-induced behaviour in human volunteers?

  Silverstone PH. et al, (1992), Psychopharmacology (Berl), 107, 140 - 141

• Commentary on 'The management of treatment-resistant affective disorder: clinical perspectives'.

  Cowen PJ., (1992), J Psychopharmacol, 6, 158 - 159

• Biological markers of depression.

  Cowen PJ. and Wood AJ., (1991), Psychol Med, 21, 831 - 836

• Serotonin receptor subtypes: implications for psychopharmacology.

  Cowen PJ., (1991), Br J Psychiatry Suppl, 7 - 14

• Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome.

  Cowen PJ. et al, (1991), Br J Psychiatry, 159, 341 - 346

• Prolactin response to the dopamine antagonist, metoclopramide, in depression.

  Anderson IM. and Cowen PJ., (1991), Biol Psychiatry, 30, 313 - 316

• Intravenous L-tryptophan and regional cerebral blood flow.

  Geaney DP. et al, (1991), Biol Psychiatry, 29, 508 - 509

• Blunted growth hormone and prolactin responses to L-tryptophan in depression; a state-dependent abnormality.

  Upadhyaya AK. et al, (1991), J Affect Disord, 21, 213 - 218

• Altered in vitro adaptive responses of lymphocyte Na+,K(+)-ATPase in patients with manic depressive psychosis.

  Wood AJ. et al, (1991), J Affect Disord, 21, 199 - 206

• The neurotransmitter basis of cognition: psychopharmacological activation studies using positron emission tomography.

  Friston KJ. et al, (1991), Ciba Found Symp, 163, 76 - 87

• Pindolol decreases prolactin and growth hormone responses to intravenous L-tryptophan.

  Smith CE. et al, (1991), Psychopharmacology (Berl), 103, 140 - 142

• Neuroendocrine responses to L-tryptophan as an index of brain serotonin function: effect of weight loss.

  Anderson I. and Cowen P., (1991), Adv Exp Med Biol, 294, 245 - 254

• Neuroendocrine and clinical responses in obsessive-compulsive disorder.

  Cowen PJ., (1991), J Psychopharmacol, 5, 438 - 439

• Lithium and 5-HT1A receptor sensitivity: a neuroendocrine study in healthy volunteers.

  Walsh AE. et al, (1991), Psychopharmacology (Berl), 105, 568 - 572

• Does metergoline selectively attenuate 5-HT mediated prolactin release?

  Ellis PM. et al, (1991), Psychopharmacology (Berl), 105, 129 - 131

• Calcium channel blockade and resistant bipolar depression

  Johnson BA. and Cowen PJ., (1991), Irish Journal of Psychological Medicine, 8, 50 - 51

• Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo.

  Gartside SE. et al, (1990), Eur J Pharmacol, 191, 391 - 400

• Sleep stability with home sleep recording and automatic sleep stage analysis.

  Sharpley AL. et al, (1990), Sleep, 13, 538 - 540

• Dieting reduces plasma tryptophan and alters brain 5-HT function in women.

  Anderson IM. et al, (1990), Psychol Med, 20, 785 - 791

• Decreased plasma tryptophan concentration in major depression: relationship to melancholia and weight loss.

  Anderson IM. et al, (1990), J Affect Disord, 20, 185 - 191

• ENDOCRINOLOGIC RESPONSES TO 5-HT

  COWEN P. et al, (1990), ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 600, 250 - 259

• Antagonist effect of MDL 73005EF on post-synaptic 5-HT(1A) receptors in the rat

  Gartside SE. and Cowen PJ., (1990), European Journal of Pharmacology, 183

• Slow wave sleep and 5-HT2 receptor sensitivity during maintenance tricyclic antidepressant treatment.

  Sharpley AL. et al, (1990), J Affect Disord, 19, 273 - 277

• Abnormal 5-HT neuroendocrine function in depression

  Cowen PJ., (1990), European Journal of Pharmacology, 183

• Antidepressants: current concepts of mode of action.

  Cowen PJ., (1990), Int Clin Psychopharmacol, 5 Suppl 3, 45 - 55

• Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease.

  Geaney DP. et al, (1990), Lancet, 335, 1484 - 1487

• Plasma concentrations of tryptophan and dieting.

  Goodwin GM. et al, (1990), BMJ, 300, 1499 - 1500

• The effect of moderate weight loss on overnight melatonin secretion.

  Anderson IM. et al, (1990), Br J Psychiatry, 156, 875 - 877

• Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.

  Gartside SE. and Cowen PJ., (1990), Eur J Pharmacol, 179, 103 - 109

• Effects of carbamazepine on dopamine- and serotonin-mediated neuroendocrine responses.

  Elphick M. et al, (1990), Arch Gen Psychiatry, 47, 135 - 140

• Effect of amitriptyline on endocrine responses to intravenous L-tryptophan.

  Cowen PJ. et al, (1990), Psychiatry Res, 31, 201 - 208

• The effects of gepirone on neuroendocrine function and temperature in humans.

  Anderson IM. et al, (1990), Psychopharmacology (Berl), 100, 498 - 503

• Metergoline abolishes the prolactin response to buspirone.

  Gregory CA. et al, (1990), Psychopharmacology (Berl), 100, 283 - 284

• Drug treatment of tricyclic resistant depression

  Chalmers JS. and Cowen PJ., (1990), International Review of Psychiatry, 2, 239 - 248

• Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.

  Sharpley AL. et al, (1990), Psychopharmacology (Berl), 101, 568 - 569

• A role for 5-HT in the action of antidepressant drugs.

  Cowen PJ., (1990), Pharmacol Ther, 46, 43 - 51

• The measurement of transmembrane cation transport in vivo in acute manic illness.

  Wood AJ. et al, (1989), Br J Psychiatry, 155, 501 - 504

• Effect of moderate weight loss on prolactin secretion in normal female volunteers.

  Anderson IM. et al, (1989), Psychiatry Res, 29, 161 - 167

• Effect of idazoxan on evening melatonin plasma concentrations in healthy volunteers.

  Grasby PM. et al, (1989), Biol Psychiatry, 26, 412 - 416

• Effects of carbamazepine on sleep in healthy volunteers.

  Yang JD. et al, (1989), Biol Psychiatry, 26, 324 - 328

• The effect of moderate weight loss on overnight growth hormone and cortisol secretion in healthy female volunteers.

  Anderson IM. et al, (1989), J Affect Disord, 16, 197 - 202

• Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors?

  Friston KJ. et al, (1989), Psychopharmacology (Berl), 98, 139 - 140

• Lithium increases 5-HT-mediated prolactin release.

  McCance SL. et al, (1989), Psychopharmacology (Berl), 99, 276 - 281

• Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression.

  Cowen PJ. et al, (1989), Psychopharmacology (Berl), 99, 230 - 232

• Lack of effect of oestradiol implant on platelet imipramine and 5-HT2 receptor binding in menopausal subjects.

  Best NR. et al, (1989), Psychopharmacology (Berl), 98

• Increased slow wave sleep with 5-HT2 receptor antagonists: detection by ambulatory EEG recording and automatic sleep stage analysis.

  Solomon RA. et al, (1989), J Psychopharmacol, 3, 125 - 129

• Decreased plasma tryptophan levels in major depression.

  Cowen PJ. et al, (1989), J Affect Disord, 16, 27 - 31

• Biological markers in depression

  Cowen PJ., (1989), Current Opinion in Psychiatry, 2, 106 - 109

• Recent views on the role of 5-hydroxytryptamine in depression

  Cowen PJ., (1988), Current Opinion in Psychiatry, 1, 56 - 59

• Binding of tritiated yohimbine to platelets in women with maternity blues.

  Best NR. et al, (1988), Psychol Med, 18, 837 - 842

• Depression resistant to tricyclic antidepressants.

  Cowen PJ., (1988), BMJ, 297, 435 - 436

• Prolactin response to tryptophan during mianserin treatment.

  Cowen PJ., (1988), Am J Psychiatry, 145, 740 - 741

• Evaluation of first night effect using ambulatory monitoring and automatic sleep stage analysis.

  Sharpley AL. et al, (1988), Sleep, 11, 273 - 276

• The effects of dieting and weight loss upon the stimulation of thyrotropin (TSH) by thyrotropin-releasing hormone (TRH) and suppression of cortisol secretion by dexamethasone in men and women.

  Goodwin GM. et al, (1988), J Affect Disord, 14, 137 - 144

• The effect of clonidine and bright light on plasma melatonin

  Grasby PM. and Cowen PJ., (1988), Human Psychopharmacology: Clinical and Experimental, 3, 43 - 46

• Neurochemical studies in normal volunteers

  Nutt DJ. and Cowen PJ., (1988), Pharmaceutical Medicine, 3, 127 - 133

• Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness.

  Elphick M. et al, (1988), J Psychopharmacol, 2, 1 - 4

• Depression resistant to tricyclic antidepressants. Adding lithium will often work

  Cowen PJ., (1988), British Medical Journal, 297, 435 - 436

• The pineal and psychiatry: still fumbling in the dark?

  Grasby PM. and Cowen PJ., (1987), Psychol Med, 17, 817 - 820

• The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers. Important implications for neuroendocrine investigations in depression.

  Goodwin GM. et al, (1987), Arch Gen Psychiatry, 44, 952 - 957

• Neuroendocrine responses to intravenous tryptophan in major depression.

  Cowen PJ. and Charig EM., (1987), Arch Gen Psychiatry, 44, 958 - 966

• Dieting changes serotonergic function in women, not men: implications for the aetiology of anorexia nervosa?

  Goodwin GM. et al, (1987), Psychol Med, 17, 839 - 842

• Diazepam alters brain 5-HT function in man: implications for the acute and chronic effects of benzodiazepines.

  Nutt DJ. and Cowen PJ., (1987), Psychol Med, 17, 601 - 607

• Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment.

  Cowen PJ. et al, (1987), J Affect Disord, 13, 45 - 50

• Dieting and weight loss in volunteers increases the number of alpha 2-adrenoceptors and 5-HT receptors on blood platelets without effect on [3H]imipramine binding.

  Goodwin GM. et al, (1987), J Affect Disord, 12, 267 - 274

• The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan.

  Idzikowski C. et al, (1987), Psychopharmacology (Berl), 93, 416 - 420

• The effect of metergoline on endocrine responses to L-tryptophan.

  McCance SL. et al, (1987), J Psychopharmacol, 1, 90 - 94

• Selective effect of lithium on cognitive performance in man.

  Glue PW. et al, (1987), Psychopharmacology (Berl), 91, 109 - 111

• Psychotropic drugs and human 5-HT neuroendocrinology

  Cowen PJ., (1987), Trends in Pharmacological Sciences, 8, 105 - 108

• Endocrine responses to tryptophan infusion in schizophrenic patients treated with neuroleptics.

  Kolakowska T. et al, (1987), Psychoneuroendocrinology, 12, 193 - 202

• BETA-ADRENOCEPTOR FUNCTION IN THE PINEAL-GLAND DURING DESIPRAMINE TREATMENT

  COWEN P., (1987), INTERNATIONAL JOURNAL OF NEUROSCIENCE, 32, 568 - 569

• Binding of yohimbine and imipramine to platelets in depressive illness.

  Braddock L. et al, (1986), Psychol Med, 16, 765 - 773

• Changes in mood, appetite and psychomotor retardation in depressed patients given ECT.

  Browning SM. and Cowen PJ., (1986), Br J Psychiatry, 149, 371 - 373

• The effect of diazepam on indices of 5-HT function in man.

  Nutt DJ. et al, (1986), Pharmacol Biochem Behav, 24, 1491 - 1495

• The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.

  Glue PW. et al, (1986), Psychopharmacology (Berl), 90, 398 - 402

• Neuroendocrine responses as a probe into the mechanisms of action of electroconvulsive therapy.

  Cowen PJ., (1986), Ann N Y Acad Sci, 462, 163 - 171

• Desipramine treatment in normal subjects. Effects on neuroendocrine responses to tryptophan and on platelet serotonin (5-HT)-related receptors.

  Cowen PJ. et al, (1986), Arch Gen Psychiatry, 43, 61 - 67

• Clomipramine enhances prolactin and growth hormone responses to L-tryptophan.

  Anderson IM. and Cowen PJ., (1986), Psychopharmacology (Berl), 89, 131 - 133

• The pharmacokinetics of L-tryptophan following its intravenous and oral administration.

  Green AR. et al, (1985), Br J Clin Pharmacol, 20, 317 - 321

• Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmission.

  Cowen PJ. et al, (1985), Br J Clin Pharmacol, 19, 799 - 805

• Effects of the contraceptive pill on sedative responses to clonidine and apomorphine in normal women.

  Chalmers JS. et al, (1985), Psychol Med, 15, 363 - 367

• Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment.

  Schächter M. et al, (1985), Br J Clin Pharmacol, 19, 453 - 457

• Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration.

  Cowen PJ. et al, (1985), Br J Clin Pharmacol, 19, 258 - 260

• The benzodiazepine antagonist, Ro 15-1788 does not decrease ethanol withdrawal convulsions in rats.

  Little HJ. et al, (1985), Eur J Pharmacol, 107, 375 - 377

• Responses of prolactin and growth hormone to L-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics.

  Cowen PJ. et al, (1985), Psychopharmacology (Berl), 86, 164 - 169

• NORADRENERGIC TRANSMISSION IN THE PINEAL-GLAND DURING DESMETHYLIMIPRAMINE TREATMENT

  COWEN P. et al, (1985), BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 19, P579 - P580

• CHANGES IN IMIPRAMINE AND ALPHA-2-ADRENOCEPTOR BINDING-SITES IN THE EARLY PUERPERIUM

  BEST N. et al, (1985), BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 19, P555 - P556

• Changes in the binding to platelets of [3H]imipramine and [3H]yohimbine in normal subjects taking amitriptyline.

  Braddock LE. et al, (1984), Neuropharmacology, 23, 285 - 286

• The effect of amitriptyline treatment on the growth hormone response to apomorphine.

  Cowen PJ. et al, (1984), Psychopharmacology (Berl), 83, 378 - 379

• PLATELET (H-3)-LSD BINDING IN PATIENTS ON CHRONIC PHENOTHIAZINE AND THIOXANTHENE THERAPY

  SCHACHTER M. et al, (1984), BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 17, P619 - P620

• Effect of beta 2-adrenoceptor agonists on serotonin biochemistry and function.

  Green AR. et al, (1984), Adv Biochem Psychopharmacol, 39, 285 - 288

• Changes in the binding to platelets of [³H]imipramine and [³H]yohimbine in normal subjects taking amitriptyline

  Braddock LE. et al, (1984), Neuropharmacology, 23, 285 - 286

• AMITRIPTYLINE REDUCES THE GROWTH-HORMONE RESPONSE TO APOMORPHINE

  BRADDOCK L. et al, (1984), BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 17, P642 - P643

• Direct radioimmunoassay and gas chromatography-mass spectrometry compared for determination of melatonin in plasma.

  Fraser S. et al, (1983), Clin Chem, 29, 1703 - 1704

• Studies on the mechanisms by which clenbuterol, a beta-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the rat.

  Nimgaonkar VL. et al, (1983), Neuropharmacology, 22, 739 - 749

• Atenolol reduces plasma melatonin concentration in man.

  Cowen PJ. et al, (1983), Br J Clin Pharmacol, 15, 579 - 581

• Changes in platelet alpha 2-adrenoceptor binding post partum: possible relation to maternity blues.

  Metz A. et al, (1983), Lancet, 1, 495 - 498

• Direct radioimmunoassay for melatonin in plasma.

  Fraser S. et al, (1983), Clin Chem, 29, 396 - 397

• The effect of chronic antidepressant administration on beta-adrenoceptor function of the rat pineal.

  Cowen PJ. et al, (1983), Br J Pharmacol, 78, 89 - 96

• Comparison of the effects of chronic desmethylimipramine administration on alpha 2- and beta-adrenoceptors in different regions of rat brain.

  Stanford C. et al, (1983), Neuroscience, 8, 161 - 164

• Further evidence for a relationship between changes in GABA concentration in rat brain and enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shock.

  Green AR. et al, (1982), Neuropharmacology, 21, 981 - 984

• Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses.

  Costain DW. et al, (1982), Lancet, 2, 400 - 404

• Abstinence symptoms after withdrawal of tranquillising drugs: is there a common neurochemical mechanism?

  Cowen PJ. and Nutt DJ., (1982), Lancet, 2, 360 - 362

• beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses.

  Cowen PJ. et al, (1982), Br J Pharmacol, 76, 265 - 270

• Unusual interactions of benzodiazepine receptor antagonists.

  Nutt DJ. et al, (1982), Nature, 295, 436 - 438

• Using Ro 15-1788 to investigate the benzodiazepine receptor in vivo: studies on the anticonvulsant and sedative effect of melatonin and the convulsant effect of the benzodiazepine Ro 05-3663.

  Green AR. et al, (1982), Psychopharmacology (Berl), 78, 293 - 295

• Repeated administration of subconvulsant doses of GABA antagonist drugs. I. Effect on seizure threshold (kindling).

  Nutt DJ. et al, (1982), Psychopharmacology (Berl), 76, 84 - 87

• Repeated administration of subconvulsant doses of GABA antagonist drugs. II. Effect on monoamine-mediated behaviour.

  Cowen PJ. et al, (1982), Psychopharmacology (Berl), 76, 88 - 91

• β‐ADRENOCEPTOR AGONISTS ENHANCE 5‐HYDROXYTRYPTAMINE‐MEDIATED BEHAVIOURAL RESPONSES

  COWEN PJ. et al, (1982), British Journal of Pharmacology, 76, 265 - 270

• Antidepressant treatment and β-adrenoceptor function in the rat pineal

  Cowen PJ. and Fraser S., (1981), British Journal of Pharmacology, 74

• Studies on the post-ictal rise in seizure threshold.

  Nutt DJ. et al, (1981), Eur J Pharmacol, 71, 287 - 295

• Ethyl beta-carboline carboxylate lowers seizure threshold and antagonizes flurazepam-induced sedation in rats.

  Cowen PJ. et al, (1981), Nature, 290, 54 - 55

• Drug-induced alterations of the post-ictal seizure threshold increase

  Cowen PJ. et al, (1981), British Journal of Pharmacology, 73

• Repeated electroconvulsive shock does not increase the susceptibility of rats to a cage convulsant (isopropylbicyclophosphate).

  Cowen PJ. et al, (1980), Neuropharmacology, 19, 1025 - 1026

• On the measurement in rats of the convulsant effect of drugs and the changes which follow electroconvulsive shock.

  Nutt DJ. et al, (1980), Neuropharmacology, 19, 1017 - 1023

• Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--II. The effects of anaesthesia and current conditions on the appearance of enhanced responses following electroconvulsive shock.

  Cowen PJ. et al, (1980), Neuropharmacology, 19, 901 - 906

• Effect of anaesthetic administration on the appearance of enhanced monoamine-mediated behaviours following electroconvulsive shock

  Cowen PJ. et al, (1980), British Journal of Pharmacology, 70

• Backing into the future: pharmacological approaches to the management of resistant depression

  Cowen PJ., Psychological Medicine

Key Publications

• Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study.

  Taylor MJ. et al, (2012), J Psychopharmacol, 26, 733 - 737
• Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartate.

  Taylor MJ. et al, (2012), Int J Neuropsychopharmacol, 15, 1541 - 1546
• Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.

  Horder J. et al, (2012), J Psychopharmacol, 26, 125 - 132
• In response to "The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?" by Trevor Norman.

  Sharpley AL. and Cowen PJ., (2012), Psychopharmacology (Berl), 221
• Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

  Taylor MJ. et al, (2012), JOURNAL OF PSYCHOPHARMACOLOGY, 26, 733 - 737

Recent Publications

• Vulnerability to depression is associated with a failure to acquire implicit social appraisals.

  Bayliss AP. et al, (2017), Cogn Emot, 31, 825 - 833
• Brain glutamate in anorexia nervosa: a magnetic resonance spectroscopy case control study at 7 Tesla.

  Godlewska BR. et al, (2017), Psychopharmacology (Berl), 234, 421 - 426
• Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies.

  Petersen I. et al, (2017), Clin Epidemiol, 9, 95 - 103
• Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration.

  Vai B. et al, (2016), Eur Neuropsychopharmacol, 26, 2000 - 2010
• Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records.

  Petersen I. et al, (2016), Schizophr Res, 176, 349 - 356